Evidence map›Paper›PMID 39695175›Full record

ArticleCell death discovery2024

MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4.

Zhuoshi Li, Shiqing Wang, Tao Guo, Xinyi Yan, Chaoqun Chen, Wenjing Zhang, Jinyao Zhao, Jinrui Zhang, Shilei Zhao, Yang Wang and 2 more

Abstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhuoshi Li *Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.
Shiqing Wang *Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.
Tao Guo *Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.
Xinyi YanDepartment of Nephrology, Dalian Municipal Central Hospital, Dalian University of Technology, Dalian, 116033, China.
Chaoqun ChenInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Wenjing ZhangInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Jinyao ZhaoInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Jinrui ZhangInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Shilei ZhaoDepartment of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.
Yang WangInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Yangfan QiInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China. yangfanshy@163.com.
Chundong GuDepartment of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China. guchundong@dmu.edu.cn.ORCID http://orcid.org/0000-0002-2981-6578

Funding

National Natural Science Foundation of China (National Science Foundation of China) Nos. 81774078
6 · The paper itself

Abstract

Metastasis-associated in colon cancer-1 (MACC1) was identified as a new player in lung cancer development, and some stemness-related genes can be novel transcriptional targets of MACC1. Cancer stem cells (CSCs) are responsible for sustaining tumorigenesis and plasticity. Both CSCs and non-CSCs are plastic and capable of undergoing phenotypic transition, especially the dedifferentiation of non-CSCs switch to CSC-like cells. However, the precise role of MACC1 during this process is largely unknown. Here, we showed that MACC1 promoted the transition from non-CSC to CSC in lung cancer. We found MACC1 was overexpressed in stemness enriched cells, enhancing the transition from no-CSCs to CSCs, while short-hairpin RNA-mediated Knockdown of MACC1 impaired this process. High-throughput sequencing and tumor specimen analysis revealed that MACC1 was negative correlated with Krüppel-like factor 4 (KLF4) expression level, which acts as a negative stemness regulator in lung cancer. Mechanistically, MACC1 delays the degradation of KLF4 mRNA by repressing the expression of microRNA-25, thereby promoting the KLF4 mRNA stabilization at the post-transcriptional level. Collectively, our findings may facilitate efforts to promote the development of precision targeted therapy for cancer stem cells in lung cancer.

Identifiers

PMID39695175
PMCPMC11655558

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.